Neuropathic cancer pain: Prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study

Palliative Medicine

Volumn 27, Issue 8, 2013, Pages 714-721

  Rayment, Clare ^a   Hjermstad, Marianne J ^b,c   Aass, Nina ^b   Kaasa, Stein ^c,d   Caraceni, Augusto ^c,e   Strasser, Florian ^f   Heitzer, Ellen ^g   Fainsinger, Robin ^h   Bennett, Michael I ⁱ  

^a St Gemma's Hospice   (United Kingdom)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^e NATIONAL CANCER INSTITUTE   (Italy)

^f LUZERNER KANTONSSPITAL   (Switzerland)

^g MEDICAL UNIVERSITY OF GRAZ   (Austria)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

analgesics; neoplasms; Neuralgia; pain; pain measurement; palliative care

Indexed keywords

ANALGESIC AGENT;

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER PAIN; CANCER RESEARCH; COGNITION; COMPUTER ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; EDMONTON CLASSIFICATION SYSTEM FOR CANCER PAIN; FEMALE; HOSPITAL PATIENT; HUMAN; HYPOTHESIS; MAJOR CLINICAL STUDY; MALE; NEUROPATHIC CANCER PAIN; NEUROPATHIC PAIN; NEUROPATHY; NOCICEPTIVE PAIN; OBSERVATIONAL STUDY; OUTPATIENT; PALLIATIVE THERAPY; PHYSICAL CAPACITY; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SOCIAL STATUS; VALIDATION PROCESS;

ANALGESICS; NEOPLASMS; NEURALGIA; PAIN; PAIN MEASUREMENT; PALLIATIVE CARE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; NEURALGIA; PAIN MEASUREMENT; PREVALENCE; QUALITY OF LIFE; SYMPTOM ASSESSMENT; YOUNG ADULT;

EID: 84882956202     PISSN: 02692163     EISSN: 1477030X     Source Type: Journal    
DOI: 10.1177/0269216312464408     Document Type: Article

References (26)

1. Torrance N, Smith BH, Bennett MI, et al. The epidemiology of chronic pain of predominantly neuropathic origin. Results from a general population survey. J Pain. 2006 ; 7: 281-289
2. Smith BH, Torrance N, Bennett MI, et al. Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clin J Pain. 2007 ; 23: 143-149
3. Bouhassira D, Lanteri-Minet M, Attal N, et al. Prevalence of chronic pain with neuropathic characteristics in the general population. Pain. 2008 ; 136: 380-387
4. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP task force on cancer pain. International association for the study of pain. Pain. 1999 ; 82: 263-274
5. Grond S, Zech D, Diefenbach C, et al. Assessment of cancer pain: a prospective evaluation in 2266 cancer patients referred to a pain service. Pain. 1996 ; 64: 107-114
6. Fainsinger RL, Nekolaichuk C, Lawlor P, et al. An international multicentre validation study of a pain classification system for cancer patients. Eur J Cancer. 2010 ; 46: 2896-2904
7. Fainsinger RL, Nekolaichuk CL, Lawlor PG, et al. A multicenter study of the revised Edmonton staging system for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage. 2005 ; 29: 224-237
8. Mercadante S, Gebbia V, David F, et al. Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain. 2009 ; 10: 594-600
9. Grond S, Radbruch L, Meuser T, et al. Assessment and treatment of neuropathic cancer pain following WHO guidelines. Pain. 1999 ; 79: 15-20
10. Knudsen AK, Brunelli C, Kaasa S, et al. Which variables are associated with pain intensity and treatment response in advanced cancer patients? Implications for a future classification system for cancer pain. Eur J Pain. 2011 ; 15: 320-327
11. Hjermstad MJ, Lie HC, Caraceni C, et al. Computer based symptom assessment is feasible in patients with advanced cancer - results from an international multi-centre study, the EPCRC-CSA. J Pain Symptom Manage. 2012 ;:
12. Karnofsky DA. The use of nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer. 1948 ; 1: 634-656
13. Fainsinger RL, Nekolaichuk CL. A 'TNM' classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer. 2008 ; 16: 547-555
14. FainsingerRLNekolaichukCLLawlorP. Edmonton Classification System for Cancer Pain (ECS-CP): Quick user guidehttp://www.palliative.org/NewPC/-pdfs/ tools/Quick%20User%20Guide-Online.pdf (accessed Oct 2012).
15. Treede RD, Jensen TS, Campbell JN, et al. Neuropathic pain, redefinition and a grading system for clinical and research purposes. Neurology. 2008 ; 70: 1630-1635
16. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993 ; 85: 365-376
17. Helbostad JL, Oldervoll LM, Fayers PM, et al. Development of a computer-administered mobility questionnaire. Support Care Cancer. 2011 ; 19: 745-755
18. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care. 1991 ; 7: 6-9
19. Daut RL, Cleeland CS, Flanery RC. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain. 1983 ; 17: 197-210
20. Freynhagen R, Baron R, Gockel U, et al. painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Curr Med Res Opin. 2006 ; 22: 1911-1920
21. Hagen NA, Stiles C, Nekolaichuk C, et al. The Alberta Breakthrough Pain Assessment Tool for cancer patients: a validation study using a Delphi process and patient think-aloud interviews. J Pain Symptom Manage. 2008 ; 35: 136-152
22. Fayers PM, Aaronson NK, Bjordal K, et al The EORTC QLQ-C30 scoring manual. 30 scoring manual. 3rd ed.Brussels: European Organisation for Research and Treatment of Cancer, 2001. Brussels: European Organisation for Research and Treatment of Cancer ; 2001 :
23. Bennett MI, Rayment C, Hjermstad M, et al. Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain. 2012 ; 153: 359-365
24. Gatti A, Sabato AF, Occhioni R, et al. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol. 2009 ; 61: 129-137
25. Bennett MI. Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med. 2011 ; 25: 553-559
26. García de Paredes ML, Del Moral González F, Martínez del Prado P, et al. First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the on study. Ann Oncol. 2011 ; 22: 924-930